MedTrace Logo

Investigate the Efficacy and Safety of Low-Glu in Patients Newly Diagnosed With Type II Diabetes Mellitus

NCT05343767 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 198

Last updated 2022-05-03

No results posted yet for this study

Summary

Ficus deltoidea leaves, Cinnamomum cassia and Black seed powdered extract have long been used for the treatment of type 2 diabetes mellitus.

Conditions

  • Type2 Diabetes Mellitus

Interventions

DIETARY_SUPPLEMENT

Natural Wellness Low-Glu low dose

The contents of 4 capsules of NW Low-Glu were equally distributed and inserted into 6 capsules size 0, and administered in 3 daily doses

DIETARY_SUPPLEMENT

Natural Wellness Low-Glu high dose

The contents of 5 capsules of NW Low-Glu were equally distributed and inserted into 6 capsules size 0, and administered in 3 daily doses

OTHER

Metformin

A total dose of 2000 mg was administered per day.

Sponsors & Collaborators

  • Natural Wellness Egypt

    lead INDUSTRY

Principal Investigators

  • Prof. Dr Samir Helmy Assaad, MD · University of Alexandria

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-09-12
Primary Completion
2021-05-30
Completion
2021-05-30

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05343767 on ClinicalTrials.gov